- This conference will be a virtual event -

Overview

The demand for cancer care is expected to increase by 40% over the next six years; however, ASCO is projecting a shortage of more than 2,200 oncologists by 2025. To meet the cancer care needs of all patients, advanced practice providers (APPs), whose education and training focus on health promotion, disease prevention, and primary care medical management, have been increasingly sought-after to fill this shortage. However, many new APPs have little background and training in oncology. As a result, oncology practices need to provide new staff with an onboarding program to help further their knowledge of hematology and oncology.

To assist APPs in their new careers in oncology-based practices, Horizon CME, in partnership with APAO, has developed “Oncology 102: An In-Depth Hematology and Oncology Review for Advanced Practice Providers.” In this two-and-a-half-day virtual program, clinicians will gain a greater understanding of cancer treatment, cancer therapies, side effects, supportive care strategies, palliative care, and more. Expert faculty will provide a detailed review of treatment strategies for hematologic disorders and solid malignancies. Participation in the program will allow APPs to build upon the foundational knowledge acquired in Oncology 101 and provide APPs with a deeper understanding of the cancer treatment strategies they need to support and care for cancer patients as part of the multidisciplinary oncology care team.

This program is appropriate for nurse practitioners, physician assistants, nurses, and pharmacists in hematology/oncology seeking an in-depth review of cancer treatment strategies and therapies.

Industry Employee** registration is date-based pricing +$400

*Student is defined as currently enrolled in an advanced learning institution and/or studying in order to enter a particular profession.

If you would like to attend as a Student, please contact [email protected] for further information.

**Defined as anyone employed by a drug, device, or diagnostic company. The primary goal of the conference is to educate practicing clinicians on the latest advances and strategies in the care of cancer patients. Because space is limited and to ensure sufficient seats are available for clinicians, Industry Employees may register as an attendee only if you have a clinical title (NP, PharmD, MD, PA, etc).

Learning Objectives

1. Outline strategies for the treatment of common solid and hematologic malignancies, including emerging and targeted therapies.
2. Summarize the role of genetics, molecular testing, and biomarkers in guiding cancer care.
3. Implement palliative care, pain management, and supportive care strategies for patients with cancer, including survivorship and quality-of-life considerations.
4. Discuss strategies for the administration and management of chemotherapy and other systemic therapies.
5. Identify and appropriately manage immune-related adverse events and therapy-specific toxicities.
6. Recognize and treat the adverse effects associated with radiation oncology effectively.
7. Appreciate the role of multidisciplinary care, including surgical interventions, in optimizing patient outcomes.

Target Audience

This activity is intended for oncology nurse practitioners, physician assistants, nurses, nurse navigators, medical assistants, and other healthcare providers involved in the care of cancer patients.

Presented By

In Partnership With